Like I said, this is like PCK using those "growth" revenue graph 4-5 years ago and has since stalled due to limitation of Painchek just like wheezo, very similar technology limitation of their core and only product and reporting was identical to how RSH is reporting right now. Also received government assistance with a spike in uptake, they might look very impressive but are from a very low baseline.
Add to My Watchlist
What is My Watchlist?
